O’Neil Health Care Weekly

XLV declined 2.1% last week, pulling back from all-time high extended levels. The index is now sitting on 21-DMA ($154) support, with
the 50-DMA ($150) 2.4% lower. Despite the pullback, the RS line is still making higher highs, warranting a continued overweight
sector positioning.

Market View

The U.S. market was shifted to a Downtrend on Friday. The S&P 500 fell over 4% and breached its 50-DMA (5,505) after briefly testing all-time highs in the prior week. It closed 5% off highs with next support <1% lower at the rising 100-DMA (5,379). The Nasdaq fell nearly 6%, breaking through its 50-DMA (17,575) early in the week and its 100-DMA (17,118) on Friday. Next support is 2.5% lower at its rising 200-DMA (16,277). The earliest eligibility for a new follow-through day will now be Thursday, September 12.

O’Neil Health Care Weekly

XLV gained 113bps last week, making a new all-time high for a third straight week. Though the sector is extended, we continue to
recommend an overweight sector positioning given its RS line is holding steady with ideas continuing to act well. Look for immediate
support at the 21-DMA ($153.31), should a pullback occur.

Market View

The U.S. market remains in a Confirmed Uptrend. The S&P 500 was up slightly for the week and continues to trade in a tight sideways range above its 10-DMA (5,590). The Nasdaq declined ~1% this week and is testing its 50-DMA (17,628). The distribution day count increased to one and three, respectively.

O’Neil Health Care Weekly

XLV gained 43bps last week, remaining at all-time highs and now up for nine straight days. Should a pullback occur, look for the rising
21-DMA ($151.61) to act as near-term support. We continue to recommend an overweight sector positioning. Though the sector is
extended, the majority of groups and leading ideas continue to act well.

Market View

The U.S. market remains in a Confirmed Uptrend. The S&P 500 continued a V-shaped recovery and closed 1.5% higher for the week, ending just 1% off all-time highs (5,670). Support is at the 10-DMA (5,536) and then the 21-DMA (5,497). The Nasdaq rose 1.4% for the week, retaking the 50-DMA (17,639), which may now act as support. It remains about 4% off all-time highs (18,671). The distribution day count is at zero and one, respectively.

O’Neil Health Care Weekly

XLV gained 1.9% last week, moving back into all-time highs. Despite strong absolute action, its RS line has begun to pullback given
the rebound in the broader market. We still recommend an overweight sector positioning as the RS line has yet to make a lower low
and ideas continue to act well. Look for immediate support at the rising 21-DMA ($149.73), followed by the 50-DMA ($147.75).

Market View

The U.S. market was shifted to a Confirmed Uptrend. Each index staged a follow-through day after posting strong weekly gains.
The S&P 500 has regained its 50-DMA (5,464) and is testing price resistance along ~5,566. The Nasdaq is slightly above its 50-DMA
(17,585) and attempting to settle above this key moving average. No distribution days on either index.